Celgosivir (CAS 121104-96-9)

Celgosivir, also known under the research code MX-3253, is a compound that has garnered interest in scientific research, particularly within the field of virology. This molecule is structurally characterized by a 6-O-butanoyl glucoside modification of castanospermine, a natural product derived from the seeds of the Castanospermum australe tree. This modification enhances its bioavailability and functional interaction with biological systems. The primary focus in the study of celgosivir is its function as an α-glucosidase I inhibitor. This activity is critical because it disrupts the proper folding and modification of viral glycoproteins. By inhibiting α-glucosidase I in the endoplasmic reticulum, celgosivir prevents the initial trimming of glucose residues from nascent glycoproteins. This leads to the misfolding of these glycoproteins, which are essential for the life cycle of various viruses. Research has shown that this disruption can hinder the maturation and proper assembly of viral particles. For instance, it has been observed that celgosivir can affect the glycosylation process of viral proteins, resulting in the production of non-infectious or less infectious viral particles. This phenomenon is notably significant in studies on viruses from the Flaviviridae family, such as Dengue and Hepatitis C viruses. In various studies, celgosivir has been utilized to explore the broader implications of glycoprotein processing in viral replication and pathogenesis. Altering the glycosylation of viral envelopes, the compound provides a means to dissect the role of specific glycan structures in viral infectivity and interactions with the immune system.